查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2030 年按聚合物类型（天然、合成）、应用（药物输送、细胞移植）、方法、地区、细分趋势分列的活细胞封装市场规模、份额、趋势分析报告
市场调查报告书
商品编码
1233203

2023-2030 年按聚合物类型（天然、合成）、应用（药物输送、细胞移植）、方法、地区、细分趋势分列的活细胞封装市场规模、份额、趋势分析报告

Live Cell Encapsulation Market Size, Share & Trends Analysis Report By Polymer Type (Natural, Synthetic), By Application (Drug Delivery, Cell Transplantation), By Method, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

活细胞封装市场的增长和趋势

Grand View Research, Inc. 的一份新报告显示，全球活细胞包封市场规模在预测期内的复合年增长率将达到 3.97%，到 2030 年将达到 2.865 亿。预计将达到美元。

在再生医学中越来越多地采用活细胞封装，增加对细胞和基因治疗的公共和私人投资，以及活细胞封装在治疗目的中越来越重要，这些都是推动该行业发展的主要因素。 此外，与药物和治疗系统的活细胞封装相关的主要优势包括易于给药、随时间控製药物释放的精确速率的能力以及提供所需的预编程药物释放。，这有望推动增长研究期间的行业。 预计在预测期内，增加对细胞和基因治疗的公共和私人资金和投资将推动市场。

例如，2022 年 6 月，Immuneel Therapeutics 筹集了 1500 万美元的 A 系列资金，用于为印度的癌症患者开发负担得起的细胞和基因疗法。 2022 年 10 月，Vita Therapeutics 筹集了 3100 万美元的 B 系列资金，用于开发神经肌肉疾病和癌症的细胞疗法。 因此，增加资金可以促进研发活动，并最终增加对活细胞封装技术的需求。 多个器官受到 COVID-19 感染的影响，关于病毒引起的慢性和急性器官损伤的研究正在增加。 组织工程策略，包括活细胞封装技术，用于治疗损伤。 例如，海藻酸盐活细胞封装技术被用于对 COVID-19 感染引起的女性生殖系统损伤进行内部激素治疗。

如您所见，COVID-19 大流行对该行业产生了积极影响。 此外，活细胞封装技术已被证明是适用于心力衰竭、糖尿病、癌症、贫血和中枢神经系统等疾病的治疗策略。 例如，封装胰岛细胞是封装在保护性胶囊中的干细胞，用于治疗 1 型糖尿病。 封装的胰岛细胞可防止低血糖和高血糖发作，无需每天进行血糖检测和胰岛素给药。 因此，活细胞封装与治疗目的的相关性越来越高，有望促进这些方法的采用。 此外，运营公司在细胞封装技术方面的合作伙伴关係和临床试验等战略举措的增加有望推动该行业的发展。

例如，2021 年 2 月，ViaCyte, Inc. 宣布启动封装细胞疗法治疗 1 型糖尿病的 2 期临床试验。 同样在 2022 年 11 月，Nanoscribe 和 BIO INX 通过推出 HYDROBIO INX 扩大了合作伙伴关係，HYDROBIO INX 是一种用于活细胞封装的新型生物相容性高分辨率生物墨水。 另一方面，高产品製造成本可能会在预测期内阻碍该行业。 活细胞封装技术必须满足严格的要求，例如生物安全性、性能、生物相容性、稳定性、纯度和可回收性，导致製造成本高。 如此高的成本对于中小企业来说是遥不可及的，并可能在一定程度上阻碍市场增长。 此外，优质原材料的有限供应也会阻碍增长。 然而，行业参与者正在不断开发高质量的原材料，以降低这项技术的製造成本。

活细胞封装市场报告亮点

  • 由于低毒性、可重复性、生物相容性、改性灵活性和生物降解性等优势，天然聚合物部分在 2022 年占据了最大份额。
  • 微囊化方法具有微囊化所具有的优势，例如预编程的药物释放曲线、易于给药以及能够在一段时间（数小时到数月）内控制融合药物的释放速率。将保持最大2022年分享。
  • 药物递送应用有可能以片剂、胶囊剂、肠胃外给药等形式应用于治疗癌症、结核病、糖尿病和类风湿性关节炎等多种疾病。
  • 到 2022 年，北美将占据最大的收入份额。 这一巨大份额可归因于该地区医疗保健基础设施的建立、人均医疗支出的增加以及对细胞和基因治疗领域的资金和投资的增加。

内容

第一章调查方法及范围

  • 调查方法
  • 调查假设
  • 信息采购
    • 购买的数据库
    • GVR 内部数据库
    • 次要信息
    • 初步调查
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证

第 2 章执行摘要

  • 市场概况
  • 片段快照
  • 竞争格局快照

第 3 章市场变量、趋势和范围

  • 母市场分析
  • 市场动态
    • 市场驱动因素分析
      • 在再生医学中越来越多地采用活细胞封装
      • 增加对细胞和基因疗法的公共和私人投资
      • 用于治疗目的的活细胞封装的重要性不断上升
    • 市场製约因素分析
      • 产品製造成本高
      • 高质量原材料的市场供应有限
  • 描绘采用情况和增长前景
  • 活细胞封装市场 - 波特分析
  • 活细胞封装市场 - SWOT 分析
  • COVID-19 影响分析

第 4 章聚合物业务分析

  • 活细胞封装市场 - 聚合物类型的变化分析
  • 天然聚合物
    • 藻酸盐
    • 壳聚醣
    • 纤维素
    • 其他
  • 合成聚合物

第 5 章方法业务分析

  • 活细胞封装市场-方法变化分析
  • 微胶囊化
  • 宏封装
  • 纳米封装

第 6 章应用业务分析

  • 活细胞封装市场 - 应用变化分析
  • 给药
  • 再生医学
  • 细胞移植
  • 其他

第7章区域业务分析

  • 活细胞封装市场：区域差异分析
  • 北美
    • SWOT 分析
    • 美国
      • 主要国家动态
      • 竞争场景
    • 加拿大
      • 主要国家动态
      • 竞争场景
  • 欧洲
    • SWOT 分析
    • 英国
      • 主要国家动态
      • 竞争场景
    • 德国
      • 主要国家动态
      • 竞争场景
    • 法国
      • 主要国家动态
      • 竞争场景
    • 意大利
      • 主要国家动态
      • 竞争场景
    • 西班牙
      • 主要国家动态
      • 竞争场景
    • 丹麦
      • 主要国家动态
      • 竞争场景
    • 瑞典
      • 主要国家动态
      • 竞争场景
    • 挪威
      • 主要国家动态
      • 竞争场景
  • 亚太地区
    • SWOT 分析
      • 2018-2030 年亚太地区的真空采血管（百万美元）
    • 日本
      • 主要国家动态
      • 竞争场景
      • 日本活细胞封装市场，2018-2030 年（百万美元）
    • 中国
      • 主要国家动态
      • 竞争场景
      • 2018-2030 年中国活细胞包封市场（百万美元）
    • 印度
      • 主要国家动态
      • 竞争场景
      • 印度活细胞封装市场，2018-2030 年（百万美元）
    • 澳大利亚
      • 主要国家动态
      • 竞争场景
      • 2018-2030 年澳大利亚活细胞封装市场（百万美元）
    • 泰国
      • 主要国家动态
      • 竞争场景
      • 泰国活细胞封装市场，2018-2030 年（百万美元）
    • 韩国
      • 主要国家动态
      • 竞争场景
      • 韩国活细胞封装市场，2018-2030 年（百万美元）
  • 拉丁美洲
    • SWOT 分析
      • 拉丁美洲活细胞封装市场，2018-2030 年（百万美元）
    • 巴西
      • 主要国家动态
      • 竞争场景
      • 巴西活细胞封装市场，2018-2030 年（百万美元）
    • 墨西哥
      • 主要国家动态
      • 竞争场景
      • 墨西哥活细胞封装市场，2018-2030 年（百万美元）
    • 阿根廷
      • 主要国家动态
      • 竞争场景
      • 阿根廷活细胞封装市场，2018-2030 年（百万美元）
  • 中东和非洲 (MEA)
    • SWOT 分析
    • 南非
      • 主要国家动态
      • 竞争场景
    • 沙特阿拉伯
      • 主要国家动态
      • 竞争场景
    • 阿拉伯联合酋长国
      • 主要国家动态
      • 竞争场景
    • 科威特
      • 主要国家动态
      • 竞争场景

第8章竞争格局

  • 参与公司概览
    • AUSTRIANOVA
    • MERCK KGAA
    • SPHERE FLUIDICS LIMITED
    • VIACYTE, INC.
    • BLACKTRACE HOLDINGS LTD (DOLOMITE MICROFLUIDICS)
    • BIO INX
    • LIVING CELL TECHNOLOGIES LIMITED
    • SIGILON THERAPEUTICS, INC.
    • ISOGEN
    • DIATRANZ OTSUKA LTD
  • 财务业绩
  • 参与公司分类
    • 市场领导者
      • 2022 年活细胞封装市场份额分析
    • 战略规划
      • 分机
      • 得到
      • 协作
      • 产品/服务发布
      • 伙伴关係
      • 其他
Product Code: GVR-4-68040-035-0

Live Cell Encapsulation Market Growth & Trends:

The global live cell encapsulation market size is projected to reach USD 286.5 million by 2030, registering a CAGR of 3.97% during the forecast period, according to a new report by Grand View Research, Inc. Increasing adoption of live cell encapsulation in regenerative medicine, rising public-private investments in cell & gene therapies, and the growing significance of live cell encapsulation for therapeutic purposes are key factors driving the industry. Furthermore, major advantages associated with live cell encapsulation of a drug or treatment system include easy administration, the possibility to control the accurate release rate of a drug over time, and the provision of desired, pre-programmed drug release anticipated to boost the industry growth over the study period. Increasing public-private funding & investments in cell and gene therapies are projected to drive the market during the forecast period.

For instance, in June 2022, Immuneel Therapeutics raised series A funding of USD 15 million to develop affordable cell and gene therapy for cancer patients in India. In October 2022, Vita Therapeutics received series B funding of USD 31 million for the development of cell therapies for neuromuscular diseases and cancers. Hence, increasing funding may boost R&D activities, ultimately increasing the demand for live cell encapsulation techniques. The COVID-19 infection affected multiple organs leading to an increase in research studies on chronic or acute organ damage caused by the virus. Tissue engineering strategies including live cell encapsulation techniques are used to treat the damages. For instance, the live cell encapsulation technique with alginate was used to deliver hormones to the body for female reproductive system damages caused due to COVID-19 infection.

Thus, the COVID-19 pandemic had a positive impact on the industry. Moreover, live cell encapsulation technology has proven to be a suitable treatment strategy for diseases, such as heart failure, diabetes, cancer, anemia, or the central nervous system. For instance, encapsulated islet cells are stem cells enclosed in a protective capsule to treat type 1 diabetes. Encapsulated islet cells prevent low and high sugar levels from occurring, and eliminate the need for daily blood glucose tests & take insulin daily. Hence, the growing significance of live cell encapsulation for therapeutic purposes is expected to drive the adoption of these methods. Furthermore, increasing strategic initiatives, such as partnerships and clinical trials on cell encapsulation technology, by operating players are expected to drive the industry.

For instance, in February 2021, ViaCyte, Inc. announced the initiation of phase 2 clinical study of encapsulated cell therapy to treat type 1 diabetes. In addition, in November 2022, Nanoscribe and BIO INX expanded their partnership with the launch of novel biocompatible high-resolution bioink HYDROBIO INX for live cell encapsulation. On the other hand, the high product manufacturing costs may hamper the industry during the forecast years. Live cell encapsulation technology must fulfill strict requirements, such as biosafety, performance, biocompatibility, stability, purity, and retrievability, leading to high production costs. Such high costs may not be affordable for small- and medium-sized companies and hamper market growth to a certain extent. In addition, the limited availability of high-quality raw materials may hinder growth. However, industry players are continuously developing high-quality raw materials, reducing the production cost of the technology.

Live Cell Encapsulation Market Report Highlights:

  • The natural polymers segment held the largest share in 2022 owing to its advantages, such as low toxicity, renewability, biocompatibility, flexibility to modification, and biodegradability
  • The microencapsulation method segment accounted for the largest share in 2022 due to the benefits offered by microencapsulation, including pre-programmed drug-release profiles, easy administration, and the ability of the technique to control the release rate of a fused drug over periods (hours to months)
  • The drug delivery application segment dominated the industry in 2022 owing to the potential application of drug delivery to treat various diseases, such as cancer, tuberculosis, diabetes, and rheumatoid arthritis, in the form of tablets, capsules, or parenteral dosage forms
  • North America held the largest revenue share in 2022. The large share can be attributed to established healthcare infrastructure, increased per capita healthcare expenditure, and rising funding & investments in cell and gene therapies space in the region

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Research Methodology
  • 1.2 Research Assumptions
    • 1.2.1 Estimates And Forecast Timeline
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 Market Variables, Trends, & Scope

  • 3.1 Parent Market Analysis
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
      • 3.2.1.1 Increasing Adoption Of Live Cell Encapsulation In Regenerative Medicine
      • 3.2.1.2 Rising Public-Private Investments In Cell And Gene Therapies
      • 3.2.1.3 Growing Significance Of Live Cell Encapsulation For Therapeutic Purposes
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 High Product Manufacturing Costs
      • 3.2.2.2 Limited Market Avalibity Of High-Quality Raw Materials
  • 3.3 Penetration &Growth Prospect Mapping
  • 3.4 Live Cell Encapsulation Market - Porter's Analysis
  • 3.5 Live Cell Encapsulation Market - Swot Analysis
  • 3.6 Covid-19 Impact Analysis

Chapter 4 Polymer Type Business Analysis

  • 4.1 Live Cell Encapsulation Market-Polymer Type Movement Analysis
  • 4.2 Natural Polymers
    • 4.2.1 Global Natural Polymers Market, 2018 - 2030 (USD Million)
    • 4.2.2 Alginate
      • 4.2.2.1 Global Alginate Market, 2018 - 2030 (USD Million)
    • 4.2.3 Chitosan
      • 4.2.3.1 Global Chitosan Market, 2018 - 2030 (USD Million)
    • 4.2.4 Cellulose
      • 4.2.4.1 Global Cellulose Market, 2018 - 2030 (USD Million)
    • 4.2.5 Others
      • 4.2.5.1 Global Others Market, 2018 - 2030 (USD Million)
  • 4.3 Synthetic Polymers
    • 4.3.1 Global Synthetic Polymers Market, 2018 - 2030 (USD Million)

Chapter 5 Method Business Analysis

  • 5.1 Live Cell Encapsulation Market-Method Movement Analysis
  • 5.2 Microencapsulation
    • 5.2.1 Global Microencapsulation Market, 2018 - 2030 (USD Million)
  • 5.3 Macroencapsulation
    • 5.3.1 Global Macroencapsulation Market, 2018 - 2030 (USD Million)
  • 5.4 Nanoencapsulation
    • 5.4.1 Global Nanoencapsulation Market, 2018 - 2030 (USD Million)

Chapter 6 Application Business Analysis

  • 6.1 Live Cell Encapsulation Market-Application Movement Analysis
  • 6.2 Drug Delivery
    • 6.2.1 Global Drug Delivery Market, 2018 - 2030 (USD Million)
  • 6.3 Regenerative Medicine
    • 6.3.1 Global Regenerative Medicine Market, 2018 - 2030 (USD Million)
  • 6.4 Cell Transplantation
    • 6.4.1 Global Cell Transplantation Market, 2018 - 2030 (USD Million)
  • 6.5 Others
    • 6.5.1 Global Others Market, 2018 - 2030 (USD Million)

Chapter 7 Regional Business Analysis

  • 7.1 Live Cell Encapsulation Market: Regional Movement Analysis
  • 7.2 North America
    • 7.2.1 Swot Analysis
      • 7.2.1.1 North America Live Cell Encapsulation Market, 2018 - 2030 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 Key Country Dynamics
      • 7.2.2.2 Competitive Scenario
      • 7.2.2.3 U.S. Live Cell Encapsulation Market, 2018 - 2030 (USD Million)
    • 7.2.3 Canada
      • 7.2.3.1 Key Country Dynamics
      • 7.2.3.2 Competitive Scenario
      • 7.2.3.3 Canada Live Cell Encapsulation Market, 2018 - 2030 (USD Million)
  • 7.3 Europe
    • 7.3.1 Swot Analysis
      • 7.3.1.1 Europe Live Cell Encapsulation Market Estimates And Forecast, 2018-2030, (Usd Million)
    • 7.3.2 U.K.
      • 7.3.2.1 Key Country Dynamics
      • 7.3.2.2 Competitive Scenario
      • 7.3.2.3 U.K. Live Cell Encapsulation Market, 2018-2030, (Usd Million)
    • 7.3.3 Germany
      • 7.3.3.1 Key Country Dynamics
      • 7.3.3.2 Competitive Scenario
      • 7.3.3.3 Germany Live Cell Encapsulation Market, 2018-2030, (Usd Million)
    • 7.3.4 France
      • 7.3.4.1 Key Country Dynamics
      • 7.3.4.2 Competitive Scenario
      • 7.3.4.3 France Live Cell Encapsulation Market, 2018-2030, (Usd Million)
    • 7.3.5 Italy
      • 7.3.5.1 Key Country Dynamics
      • 7.3.5.2 Competitive Scenario
      • 7.3.5.3 Italy Live Cell Encapsulation Market, 2018-2030, (Usd Million)
    • 7.3.6 Spain
      • 7.3.6.1 Key Country Dynamics
      • 7.3.6.2 Competitive Scenario
      • 7.3.6.3 Spain Live Cell Encapsulation Market, 2018-2030, (Usd Million)
    • 7.3.7 Denmark
      • 7.3.7.1 Key Country Dynamics
      • 7.3.7.2 Competitive Scenario
      • 7.3.7.3 Denmark Live Cell Encapsulation Market, 2018-2030, (Usd Million)
    • 7.3.8 Sweden
      • 7.3.8.1 Key Country Dynamics
      • 7.3.8.2 Competitive Scenario
      • 7.3.8.3 Sweden Live Cell Encapsulation Market, 2018-2030, (Usd Million)
    • 7.3.9 Norway
      • 7.3.9.1 Key Country Dynamics
      • 7.3.9.2 Competitive Scenario
      • 7.3.9.3 Norway Live Cell Encapsulation Market, 2018-2030, (Usd Million)
  • 7.4 Asia Pacific
    • 7.4.1 Swot Analysis
      • 7.4.1.1 Asia Pacific Vacuum Blood Collection Tube, 2018-2030, (Usd Million)
    • 7.4.2 Japan
      • 7.4.2.1 Key Country Dynamics
      • 7.4.2.2 Competitive Scenario
      • 7.4.2.3 Japan Live Cell Encapsulation Market, 2018-2030, (Usd Million)
    • 7.4.3 China
      • 7.4.3.1 Key Country Dynamics
      • 7.4.3.2 Competitive Scenario
      • 7.4.3.3 China Live Cell Encapsulation Market, 2018-2030, (Usd Million)
    • 7.4.4 India
      • 7.4.4.1 Key Country Dynamics
      • 7.4.4.2 Competitive Scenario
      • 7.4.4.3 India Live Cell Encapsulation Market, 2018-2030, (Usd Million)
    • 7.4.5 Australia
      • 7.4.5.1 Key Country Dynamics
      • 7.4.5.2 Competitive Scenario
      • 7.4.5.3 Australia Live Cell Encapsulation Market, 2018-2030, (Usd Million)
    • 7.4.6 Thailand
      • 7.4.6.1 Key Country Dynamics
      • 7.4.6.2 Competitive Scenario
      • 7.4.6.3 Thailand Live Cell Encapsulation Market, 2018-2030, (Usd Million)
    • 7.4.7 South Korea
      • 7.4.7.1 Key Country Dynamics
      • 7.4.7.2 Competitive Scenario
      • 7.4.7.3 South Korea Live Cell Encapsulation Market, 2018-2030, (Usd Million)
  • 7.5 Latin America
    • 7.5.1 Swot Analysis
      • 7.5.1.1 Latin America Live Cell Encapsulation Market, 2018-2030, (Usd Million)
    • 7.5.2 Brazil
      • 7.5.2.1 Key Country Dynamics
      • 7.5.2.2 Competitive Scenario
      • 7.5.2.3 Brazil Live Cell Encapsulation Market, 2018-2030, (Usd Million)
    • 7.5.3 Mexico
      • 7.5.3.1 Key Country Dynamics
      • 7.5.3.2 Competitive Scenario
      • 7.5.3.3 Mexico Live Cell Encapsulation Market, 2018-2030, (Usd Million)
    • 7.5.4 Argentina
      • 7.5.4.1 Key Country Dynamics
      • 7.5.4.2 Competitive Scenario
      • 7.5.4.3 Argentina Live Cell Encapsulation Market, 2018-2030, (Usd Million)
  • 7.6 Middle East & Africa (Mea)
    • 7.6.1 Swot Analysis
      • 7.6.1.1 Mea Live Cell Encapsulation Market Estimates And Forecast, 2018-2030, (Usd Million)
    • 7.6.2 South Africa
      • 7.6.2.1 Key Country Dynamics
      • 7.6.2.2 Competitive Scenario
      • 7.6.2.3 South Africa Live Cell Encapsulation Market Estimates And Forecast, 2018-2030, (Usd Million)
    • 7.6.3 Saudi Arabia
      • 7.6.3.1 Key Country Dynamics
      • 7.6.3.2 Competitive Scenario
      • 7.6.3.3 Saudi Arabia Live Cell Encapsulation Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.6.4 Uae
      • 7.6.4.1 Key Country Dynamics
      • 7.6.4.2 Competitive Scenario
      • 7.6.4.3 Uae Live Cell Encapsulation Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.6.5 Kuwait
      • 7.6.5.1 Key country dynamics
      • 7.6.5.2 Competitive scenario
      • 7.6.5.3 Kuwait live cell encapsulation market estimates and forecast, 2018-2030 (USD million)

Chapter 8 Competitive Landscape

  • 8.1 Participant's Overview
    • 8.1.1 AUSTRIANOVA
    • 8.1.2 MERCK KGAA
    • 8.1.3 SPHERE FLUIDICS LIMITED
    • 8.1.4 VIACYTE, INC.
    • 8.1.5 BLACKTRACE HOLDINGS LTD (DOLOMITE MICROFLUIDICS)
    • 8.1.6 BIO INX
    • 8.1.7 LIVING CELL TECHNOLOGIES LIMITED
    • 8.1.8 SIGILON THERAPEUTICS, INC.
    • 8.1.9 ISOGEN
    • 8.1.10 DIATRANZ OTSUKA LTD
  • 8.2 Financial Performance
  • 8.3 Participant Categorization
    • 8.3.1 Market Leaders
      • 8.3.1.1 Live Cell Encapsulation Market Share Analysis, 2022
    • 8.3.2 Strategy Mapping
      • 8.3.2.1 Expansion
      • 8.3.2.2 Acquisition
      • 8.3.2.3 Collaborations
      • 8.3.2.4 Product/service launch
      • 8.3.2.5 Partnerships
      • 8.3.2.6 Others

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
  • Table 4 Global live cell encapsulation market, by method, 2018 - 2030 (USD Million)
  • Table 5 Global live cell encapsulation market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global live cell encapsulation market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America live cell encapsulation market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
  • Table 9 North America live cell encapsulation market, by method, 2018 - 2030 (USD Million)
  • Table 10 North America live cell encapsulation market, by application, 2018 - 2030 (USD Million)
  • Table 11 U.S. live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
  • Table 12 U.S. live cell encapsulation market, by method, 2018 - 2030 (USD Million)
  • Table 13 U.S. live cell encapsulation market, by application, 2018 - 2030 (USD Million)
  • Table 14 Canada live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
  • Table 15 Canada live cell encapsulation market, by method, 2018 - 2030 (USD Million)
  • Table 16 Canada live cell encapsulation market, by application, 2018 - 2030 (USD Million)
  • Table 17 Europe live cell encapsulation market, by country, 2018 - 2030 (USD Million)
  • Table 18 Europe live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
  • Table 19 Europe live cell encapsulation market, by method, 2018 - 2030 (USD Million)
  • Table 20 Europe live cell encapsulation market, by application, 2018 - 2030 (USD Million)
  • Table 21 U.K. live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
  • Table 22 U.K. live cell encapsulation market, by method, 2018 - 2030 (USD Million)
  • Table 23 U.K. live cell encapsulation market, by application, 2018 - 2030 (USD Million)
  • Table 24 Germany live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
  • Table 25 Germany live cell encapsulation market, by method, 2018 - 2030 (USD Million)
  • Table 26 Germany live cell encapsulation market, by application, 2018 - 2030 (USD Million)
  • Table 27 France live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
  • Table 28 France live cell encapsulation market, by method, 2018 - 2030 (USD Million)
  • Table 29 France live cell encapsulation market, by application, 2018 - 2030 (USD Million)
  • Table 30 Italy live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
  • Table 31 Italy live cell encapsulation market, by method, 2018 - 2030 (USD Million)
  • Table 32 Italy live cell encapsulation market, by application, 2018 - 2030 (USD Million)
  • Table 33 Spain live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
  • Table 34 Spain live cell encapsulation market, by method, 2018 - 2030 (USD Million)
  • Table 35 Spain live cell encapsulation market, by application, 2018 - 2030 (USD Million)
  • Table 36 Denmark live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
  • Table 37 Denmark live cell encapsulation market, by method, 2018 - 2030 (USD Million)
  • Table 38 Denmark live cell encapsulation market, by application, 2018 - 2030 (USD Million)
  • Table 39 Sweden live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
  • Table 40 Sweden live cell encapsulation market, by method, 2018 - 2030 (USD Million)
  • Table 41 Sweden live cell encapsulation market, by application, 2018 - 2030 (USD Million)
  • Table 42 Norway live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
  • Table 43 Norway live cell encapsulation market, by method, 2018 - 2030 (USD Million)
  • Table 44 Norway live cell encapsulation market, by application, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific live cell encapsulation market, by country, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific live cell encapsulation market, by method, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific live cell encapsulation market, by application, 2018 - 2030 (USD Million)
  • Table 49 Japan live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
  • Table 50 Japan live cell encapsulation market, by method, 2018 - 2030 (USD Million)
  • Table 51 Japan live cell encapsulation market, by application, 2018 - 2030 (USD Million)
  • Table 52 China live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
  • Table 53 China live cell encapsulation market, by method, 2018 - 2030 (USD Million)
  • Table 54 China live cell encapsulation market, by application, 2018 - 2030 (USD Million)
  • Table 55 India live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
  • Table 56 India live cell encapsulation market, by method, 2018 - 2030 (USD Million)
  • Table 57 India live cell encapsulation market, by application, 2018 - 2030 (USD Million)
  • Table 58 Australia live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
  • Table 59 Australia live cell encapsulation market, by method, 2018 - 2030 (USD Million)
  • Table 60 Australia live cell encapsulation market, by application, 2018 - 2030 (USD Million)
  • Table 61 Thailand live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
  • Table 62 Thailand live cell encapsulation market, by method, 2018 - 2030 (USD Million)
  • Table 63 Thailand live cell encapsulation market, by application, 2018 - 2030 (USD Million)
  • Table 64 South Korea live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
  • Table 65 South Korea live cell encapsulation market, by method, 2018 - 2030 (USD Million)
  • Table 66 South Korea live cell encapsulation market, by application, 2018 - 2030 (USD Million)
  • Table 67 Latin America live cell encapsulation market, by country, 2018 - 2030 (USD Million)
  • Table 68 Latin America live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
  • Table 69 Latin America live cell encapsulation market, by method, 2018 - 2030 (USD Million)
  • Table 70 Latin America live cell encapsulation market, by application, 2018 - 2030 (USD Million)
  • Table 71 Brazil live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
  • Table 72 Brazil live cell encapsulation market, by method, 2018 - 2030 (USD Million)
  • Table 73 Brazil live cell encapsulation market, by application, 2018 - 2030 (USD Million)
  • Table 74 Mexico live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
  • Table 75 Mexico live cell encapsulation market, by method, 2018 - 2030 (USD Million)
  • Table 76 Mexico live cell encapsulation market, by application, 2018 - 2030 (USD Million)
  • Table 77 Argentina live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
  • Table 78 Argentina live cell encapsulation market, by method, 2018 - 2030 (USD Million)
  • Table 79 Argentina live cell encapsulation market, by application, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa live cell encapsulation market, by country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa live cell encapsulation market, by method, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa live cell encapsulation market, by application, 2018 - 2030 (USD Million)
  • Table 84 South Africa live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
  • Table 85 South Africa live cell encapsulation market, by method, 2018 - 2030 (USD Million)
  • Table 86 South Africa live cell encapsulation market, by application, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia live cell encapsulation market, by method, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia live cell encapsulation market, by application, 2018 - 2030 (USD Million)
  • Table 90 UAE live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
  • Table 91 UAE live cell encapsulation market, by method, 2018 - 2030 (USD Million)
  • Table 92 UAE live cell encapsulation market, by application, 2018 - 2030 (USD Million)
  • Table 93 Kuwait live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait live cell encapsulation market, by method, 2018 - 2030 (USD Million)
  • Table 95 Kuwait live cell encapsulation market, by application, 2018 - 2030 (USD Million)
  • Table 96 Participant's overview
  • Table 97 Financial performance
  • Table 98 Key companies undergoing expansions
  • Table 99 Key companies undergoing acquisitions
  • Table 100 Key companies undergoing collaborations
  • Table 101 Key companies launching new products/services
  • Table 102 Key companies undergoing partnerships
  • Table 103 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market summary, 2022 (USD Million)
  • Fig. 9 Market segmentation & scope
  • Fig. 10 Market driver impact
  • Fig. 11 Market restraint impact
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 Porter's analysis
  • Fig. 14 SWOT analysis
  • Fig. 15 Live cell encapsulation market: Polymer type outlook and key takeaways
  • Fig. 16 Live cell encapsulation market: Polymer type movement analysis
  • Fig. 17 Global natural polymers market, 2018 - 2030 (USD Million)
  • Fig. 18 Global alginate market, 2018 - 2030 (USD Million)
  • Fig. 19 Global chitosan market, 2018 - 2030 (USD Million)
  • Fig. 20 Global cellulose market, 2018 - 2030 (USD Million)
  • Fig. 21 Global others market, 2018 - 2030 (USD Million)
  • Fig. 22 Global synthetic polymers market, 2018 - 2030 (USD Million)
  • Fig. 23 Live cell encapsulation market: Method outlook and key takeaways
  • Fig. 24 Live cell encapsulation market: Method movement analysis
  • Fig. 25 Global microencapsulation market, 2018 - 2030 (USD Million)
  • Fig. 26 Global macroencapsulation market, 2018 - 2030 (USD Million)
  • Fig. 27 Global nanoencapsulation market, 2018 - 2030 (USD Million)
  • Fig. 28 Live cell encapsulation market: Application outlook and key takeaways
  • Fig. 29 Live cell encapsulation market: Application movement analysis
  • Fig. 30 Global drug delivery market, 2018 - 2030 (USD Million)
  • Fig. 31 Global regenerative medicine market, 2018 - 2030 (USD Million)
  • Fig. 32 Global cell transplantation market, 2018 - 2030 (USD Million)
  • Fig. 33 Global others market, 2018 - 2030 (USD Million)
  • Fig. 34 Live cell encapsulation market: Regional outlook and key takeaways
  • Fig. 35 North America: SWOT Analysis
  • Fig. 36 North America live cell encapsulation market, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. key country dynamics
  • Fig. 38 U.S. live cell encapsulation market, 2018 - 2030 (USD Million)
  • Fig. 39 Canada key country dynamics
  • Fig. 40 Canada live cell encapsulation market, 2018 - 2030 (USD Million)
  • Fig. 41 Europe: SWOT Analysis
  • Fig. 42 Europe live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 U.K. key country dynamics
  • Fig. 44 U.K. live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Germany key country dynamics
  • Fig. 46 Germany live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 France key country dynamics
  • Fig. 48 France live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Italy key country dynamics
  • Fig. 50 Italy live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Spain key country dynamics
  • Fig. 52 Spain live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Denmark key country dynamics
  • Fig. 54 Denmark live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Sweden key country dynamics
  • Fig. 56 Sweden live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Norway key country dynamics
  • Fig. 58 Norway live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Asia-Pacific: SWOT Analysis
  • Fig. 60 Asia-Pacific live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Japan key country dynamics
  • Fig. 62 Japan live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 China key country dynamics
  • Fig. 64 China live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 India key country dynamics
  • Fig. 66 India live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Australia key country dynamics
  • Fig. 68 Australia live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Thailand key country dynamics
  • Fig. 70 Thailand live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 South Korea key country dynamics
  • Fig. 72 South Korea live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 Latin America: SWOT Analysis
  • Fig. 74 Latin America live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Brazil key country dynamics
  • Fig. 76 Brazil live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Mexico key country dynamics
  • Fig. 78 Mexico live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 Argentina key country dynamics
  • Fig. 80 Argentina live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 MEA: SWOT Analysis
  • Fig. 82 MEA live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 South Africa key country dynamics
  • Fig. 84 South Africa live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Saudi Arabia key country dynamics
  • Fig. 86 Saudi Arabia live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 UAE key country dynamics
  • Fig. 88 UAE live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 Kuwait key country dynamics
  • Fig. 90 Kuwait live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 91 Market participant categorization
  • Fig. 92 Live cell encapsulation market share analysis, 2022
  • Fig. 93 Strategy framework